October, 2015 | Asepticenclosures

Wild Sexx capsules: Don’t buy, don’t use, FDA says

(RNN) – Wild Sexx capsules, don’t buy, don’t use, the FDA says, warning that the sexual-enhancement product contains undeclared ingredients that may lower blood pressure to dangerous levels. Do not buy, do not use, Ultra SX, Fuel Up High Octane, APEXX, Super Dragon 600 or Paradise Suplemento Natural Ultra Plus capsules, the U.S. Food and Drug Administration said in news releases. All the products, …

Wild Sexx capsules: Don’t buy, don’t use, FDA says Read More »

Imprimis Pharmaceuticals Hits New 12-Month Low at $5.91 (IMMY)

Leave a Comment / blog, FDA News, Pharmaceutical Industry News / By admin

Imprimis Pharmaceuticals (NASDAQ:IMMY)’s share price reached a new 52-week low during trading on Tuesday , ARN reports. The stock traded as low as $5.91 and last traded at $6.00, with a volume of 42,490 shares trading hands. The stock had previously closed at $6.75. Several research firms have commented on IMMY. Zacks upgraded Imprimis Pharmaceuticals from a “sell” rating …

Imprimis Pharmaceuticals Hits New 12-Month Low at $5.91 (IMMY) Read More »

Warning to 200 patients of chemotherapy drug risk

Leave a Comment / blog, Compounding News, Hospital Industry News / By admin

Approximately 200 cancer patients have been warned they may have been given potentially contaminated chemotherapy drugs. The Health Service Executive said it was notified this week of a “precautionary” recall of a number of batches of chemotherapy drugs manufactured between September 29 and October 12. However, one woman being treated for cancer told RTÉ’s Liveline …

Warning to 200 patients of chemotherapy drug risk Read More »

FDA approves use of OxyContin in pediatrics

Leave a Comment / blog, FDA News, Hospital Industry News, Pharmaceutical Industry News, Research News / By admin

The FDA has approved OxyContin use for children as young as 11. The department says this is a symbolic move as many doctors have already been prescribing these medications to children. Many Senators are concerned with the risks of starting children on the drug so young. Senator Joe Manchin of West Virginia says his state’s …

FDA approves use of OxyContin in pediatrics Read More »

FDA Warning Letters: Seafood HACCP, Acidified Foods, Drug Residue

Leave a Comment / blog, FDA News, Research News / By admin

A seafood processing company in Texas was warned about ongoing problems meeting federal seafood HACCP regulations in the latest batch of posted warning letters from the U.S. Food and Drug Administration (FDA). Gladys’ Seafood Inc. of Buda, TX, was told in a June 25, 2015, warning letter that FDA inspectors had found numerous violations of the seafood …

FDA Warning Letters: Seafood HACCP, Acidified Foods, Drug Residue Read More »

Advaxis offers a tardy defense after FDA puts cancer vaccine on hold

Leave a Comment / blog, FDA News, Hospital Industry News, Pharmaceutical Industry News / By admin

Two weeks after reporting that its cancer vaccine spurred a positive response among a group of cervical cancer patients in a small clinical trial, Advaxis ($ADXS) waited until after the market closed today to reveal that the FDA has placed the same cancer vaccine–axalimogene filolisbac (ADXS-HPV)–on a clinical hold, slamming the brakes on four studies. …

Advaxis offers a tardy defense after FDA puts cancer vaccine on hold Read More »

FDA approves lung cancer drug

Leave a Comment / blog, FDA News, Pharmaceutical Industry News, Research News / By admin

Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer. The Food and Drug Administration approved Keytruda for advanced non-small cell lung cancer patients who have seen their tumors spread after taking other therapies. The disease accounts for roughly seven …

FDA approves lung cancer drug Read More »

Month: October 2015